Patience Maghah Awafong

Mrs. Patience Maghah Awafong

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2025 in Toxins
Verified
Journal Article
Open access
PDF file
TFTemitope Richard Fagbohun
Temitope Richard Fagbohun
QNQueenta Ngum Nji
Queenta Ngum Nji
VOViola O. Okechukwu
Viola O. Okechukwu
OAOluwasola Abayomi Adelusi
Oluwasola Abayomi Adelusi
LNLungani Amanda Nyathi
Lungani Amanda Nyathi
PNPatrick Berka Njobeh
Patrick Berka Njobeh
Aflatoxins (AFs), harmful secondary metabolites produced by the genus Aspergillus, particularly Aspergillus flavus and Aspergillus parasiticus, are one of the best-known potent mycotoxins, posing a significant risk to public health. The primary type, especially aflatoxin B1 (AFB1), is a potent carcinogen associated with liver cancer, immunosuppression, and other health problems. Environmental factors such as high temperatures, humidity, and inadequate storage conditions promote the formation of aflatoxin in staple foods such as maize, peanuts, and rice. Immunocompromised individuals, including those with HIV/AIDS, hepatitis, cancer, or diabetes, are at increased risk due to their reduced detoxification capacity and weakened immune defenses. Chronic exposure to AF in these populations exacerbates liver damage, infection rates, and disease progression, particularly in developing countries and moderate-income populations where food safety regulations are inadequate and reliance on contaminated staple foods is widespread. Biomarkers such as aflatoxin-albumin complexes, urinary aflatoxin M1, and aflatoxin (AF) DNA adducts provide valuable insights but remain underutilized in resource-limited settings. Despite the globally recognized health risk posed by AF, research focused on monitoring human exposure remains limited, particularly among immunocompromised individuals. This dynamic emphasizes the need for targeted studies and interventions to address the particular risks faced by immunocompromised individuals. This review provides an up-to-date overview of AF exposure in immunocompromised populations, including individuals with cancer, hepatitis, diabetes, malnutrition, pregnant women, and the elderly. It also highlights exposure pathways, biomarkers, and biomonitoring strategies, while emphasizing the need for targeted interventions, advanced diagnostics, and policy frameworks to mitigate health risks in these vulnerable groups. Addressing these gaps is crucial to reducing the health burden and developing public health strategies in high-risk regions.

22 October 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
PAPatience Maghah Awafong
Patience Maghah Awafong
VOViola O. Okechukwu
Viola O. Okechukwu
TFTemitope Richard Fagbohun
Temitope Richard Fagbohun
OAOluwasola Abayomi Adelusi
Oluwasola Abayomi Adelusi
OAOluwafemi Adebo
Oluwafemi Adebo
JMJulian Qedizaba Mthombeni
Julian Qedizaba Mthombeni
Aflatoxins (AFs) are toxic metabolites produced by Aspergillus flavus (A. flavus) and Aspergillus parasiticus (A. parasiticus) that contaminate food and feed, posing serious health risks to humans and animals. Consumption of aflatoxin-contaminated foods can cause aflatoxicosis, a serious condition characterised by acute or chronic toxicity. Due to their prevalence, especially in humid regions such as sub-Saharan Africa, proper management is essential for food safety and public health. While traditional methods for controlling aflatoxins can be effective, they are often costly and may introduce harmful chemicals into food, posing risks to the environment and human health. This review paper extensively analyses the toxin binders used to mitigate aflatoxin contamination, discussing their mechanisms of action and effectiveness. It also explores the transition from traditional aflatoxin management strategies to greener alternatives, with a focus on the emerging field of green nanotechnology. Additionally, this paper examines the biosynthesis of nanoparticles (NPs) using metal salt solutions and plant extracts, and their efficacy as inhibitors of aflatoxin-producing fungi and their toxins, demonstrating high effectiveness with minimal toxicity to human health and the environment. Furthermore, the article explores the integration of green nanotechnology into sustainable aflatoxin management and discusses future research directions for developing even more potent interventions through nano-encapsulation with β-cyclodextrin (β-CD).